帕罗西汀-话题@MedSci

#帕罗西汀#

5篇内容 | 602人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1941118, encodeId=fb771941118eb, content=<a href='/topic/show?id=fb954850eea' target=_blank style='color:#2F92EE;'>#帕罗西汀#</a>, objectTitle=Cent European J Urol：帕罗西汀，氟西汀和达泊西汀在社会经济地位低下且终生早泄的患者中的治疗效果比较, objectType=article, longId=188902, objectId=1588188902ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1588188902ee, replyNumber=0, likeNumber=41, createdTime=2020-12-01, rootId=0, userName=vividelife, userId=c279140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1588188902ee, moduleTitle=Cent European J Urol：帕罗西汀，氟西汀和达泊西汀在社会经济地位低下且终生早泄的患者中的治疗效果比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1588188902ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941117, encodeId=3777194111ee6, content=<a href='/topic/show?id=fb954850eea' target=_blank style='color:#2F92EE;'>#帕罗西汀#</a>, objectTitle=Int J Impot Res：多巴胺基因多态性与早泄病人对帕罗西汀和依他普伦响应关系的研究, objectType=article, longId=113098, objectId=7a6c113098ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a6c113098ea, replyNumber=0, likeNumber=48, createdTime=2017-10-05, rootId=0, userName=vividelife, userId=c279140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a6c113098ea, moduleTitle=Int J Impot Res：多巴胺基因多态性与早泄病人对帕罗西汀和依他普伦响应关系的研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a6c113098ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941116, encodeId=45b01941116c2, content=<a href='/topic/show?id=fb954850eea' target=_blank style='color:#2F92EE;'>#帕罗西汀#</a>, objectTitle=Pharmacotherapy：老年抑郁患者使用帕罗西汀是否增加死亡风险？, objectType=article, longId=96608, objectId=42939660827, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42939660827, replyNumber=0, likeNumber=51, createdTime=2017-06-04, rootId=0, userName=vividelife, userId=c279140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42939660827, moduleTitle=Pharmacotherapy：老年抑郁患者使用帕罗西汀是否增加死亡风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42939660827)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941115, encodeId=710c1941115d6, content=<a href='/topic/show?id=fb954850eea' target=_blank style='color:#2F92EE;'>#帕罗西汀#</a>, objectTitle=GSK召回特定批次盐酸帕罗西汀制剂, objectType=article, longId=34917, objectId=43773491ef5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43773491ef5, replyNumber=0, likeNumber=41, createdTime=2014-09-27, rootId=0, userName=vividelife, userId=c279140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43773491ef5, moduleTitle=GSK召回特定批次盐酸帕罗西汀制剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43773491ef5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941114, encodeId=bee0194111431, content=<a href='/topic/show?id=fb954850eea' target=_blank style='color:#2F92EE;'>#帕罗西汀#</a>, objectTitle=FDA：小剂量帕罗西汀获准用于治疗潮热, objectType=article, longId=21059, objectId=43e5210590f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43e5210590f, replyNumber=0, likeNumber=44, createdTime=2014-02-28, rootId=0, userName=vividelife, userId=c279140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43e5210590f, moduleTitle=FDA：小剂量帕罗西汀获准用于治疗潮热, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43e5210590f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

帕罗西汀

2020-05-29

vividelife (审核中...)

前往app查看评论内容

#帕罗西汀#

Cent European J Urol：帕罗西汀，氟西汀和达泊西汀在社会经济地位低下且终生早泄的患者中的治疗效果比较

2020-12-01

vividelife (审核中...)

前往app查看评论内容

#帕罗西汀#

Int J Impot Res：多巴胺基因多态性与早泄病人对帕罗西汀和依他普伦响应关系的研究

2017-10-05

vividelife (审核中...)

前往app查看评论内容

#帕罗西汀#

Pharmacotherapy：老年抑郁患者使用帕罗西汀是否增加死亡风险？

2017-06-04

vividelife (审核中...)

前往app查看评论内容

#帕罗西汀#

GSK召回特定批次盐酸帕罗西汀制剂

2014-09-27

vividelife (审核中...)

前往app查看评论内容

#帕罗西汀#

FDA：小剂量帕罗西汀获准用于治疗潮热

2014-02-28

科室
- - 订阅+
  - 更多科室
工具
服务